Summit Trail Advisors LLC Grows Stock Position in Colgate-Palmolive (NYSE:CL)

Summit Trail Advisors LLC boosted its stake in shares of Colgate-Palmolive (NYSE:CL) by 11.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,748 shares of the company’s stock after purchasing an additional 488 shares during the quarter. Summit Trail Advisors LLC’s holdings in Colgate-Palmolive were worth $378,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the stock. FMR LLC increased its position in shares of Colgate-Palmolive by 27.3% in the 3rd quarter. FMR LLC now owns 5,597,742 shares of the company’s stock valued at $398,055,000 after purchasing an additional 1,199,660 shares during the last quarter. AEGON ASSET MANAGEMENT UK Plc acquired a new stake in Colgate-Palmolive in the fourth quarter valued at $62,728,000. Assenagon Asset Management S.A. lifted its holdings in Colgate-Palmolive by 92.2% during the 4th quarter. Assenagon Asset Management S.A. now owns 1,436,054 shares of the company’s stock worth $114,468,000 after buying an additional 688,733 shares during the last quarter. Envestnet Asset Management Inc. boosted its position in shares of Colgate-Palmolive by 225.4% during the 3rd quarter. Envestnet Asset Management Inc. now owns 930,072 shares of the company’s stock worth $66,137,000 after acquiring an additional 644,205 shares in the last quarter. Finally, Bank of Nova Scotia increased its holdings in shares of Colgate-Palmolive by 188.5% in the 3rd quarter. Bank of Nova Scotia now owns 883,272 shares of the company’s stock valued at $62,809,000 after acquiring an additional 577,114 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 1.0 %

NYSE CL opened at $94.08 on Wednesday. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 13.21. The stock has a market capitalization of $77.19 billion, a P/E ratio of 29.77, a P/E/G ratio of 3.43 and a beta of 0.40. Colgate-Palmolive has a 52-week low of $67.62 and a 52-week high of $94.21. The firm has a 50-day moving average price of $88.64 and a 200 day moving average price of $82.63.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, April 26th. The company reported $0.86 EPS for the quarter, beating the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The business had revenue of $5.07 billion during the quarter, compared to analysts’ expectations of $4.96 billion. During the same period last year, the firm earned $0.73 EPS. The company’s quarterly revenue was up 6.2% compared to the same quarter last year. Equities research analysts expect that Colgate-Palmolive will post 3.52 EPS for the current year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.13%. The ex-dividend date is Friday, April 19th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 63.29%.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, insider Jennifer Daniels sold 3,538 shares of the stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $84.67, for a total value of $299,562.46. Following the completion of the transaction, the insider now directly owns 59,698 shares of the company’s stock, valued at $5,054,629.66. The sale was disclosed in a filing with the SEC, which is available at this link. In related news, CEO Noel R. Wallace sold 50,000 shares of the business’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the sale, the chief executive officer now directly owns 274,179 shares in the company, valued at approximately $22,797,983.85. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Jennifer Daniels sold 3,538 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $84.67, for a total transaction of $299,562.46. Following the transaction, the insider now owns 59,698 shares of the company’s stock, valued at $5,054,629.66. The disclosure for this sale can be found here. Insiders sold 159,048 shares of company stock worth $13,336,846 over the last 90 days. Company insiders own 0.34% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on CL shares. Evercore ISI upped their price target on Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a report on Monday, April 8th. Barclays upped their price objective on shares of Colgate-Palmolive from $84.00 to $85.00 and gave the company an “equal weight” rating in a research note on Tuesday, April 30th. The Goldman Sachs Group started coverage on Colgate-Palmolive in a report on Friday, March 1st. They issued a “buy” rating and a $93.00 target price for the company. UBS Group lifted their price target on Colgate-Palmolive from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Monday, January 29th. Finally, StockNews.com downgraded Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 20th. Three investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $91.44.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.